Hemodynamic Venous Congestion Ultrasound (VExUS) by ICU Nurses in Sepsis Patients.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegion Örebro County
About this trial
Sepsis is a serious condition where the body's immune response to infection overreacts, leading to organ damage and death. Venous congestion, a buildup of blood in the veins, can occur in sepsis and contribute to organ injury. VExUS (Venous Excess Ultrasound Score) is an ultrasound method that can detect congestion early. This study examines whether ICU nurses, after training, can perform VExUS reliably, explores their experiences, and investigates links between VExUS findings and clinical outcomes.
Eligibility criteria
Qualifiers
Patients with suspected or verified sepsis according to the Sepsis 3 criteria (suspected or confirmed infection), ≥qSOFA (systolic blood pressure < 90 mmHg, GCS ≤ 13, respiratory rate ≥ 22 per minute) or rise in SOFA score ≥ 2 points and admitted to the ICU.
≥18 years of age.
Disqualifiers
Patients with preexisting liver cirrhosis.
Pregnancy.
Trial design
Treatments tested in this trial
- Education in performing hemodynamic diagnostic ultrasound of venous congestion
- Hemodynamic diagnostic ultrasound of venous congestion
Treatment groups
46 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Region Örebro County
Lead sponsor
Örebro University, Sweden
Collaborator
Region Östergötland
Collaborator
Dalarna County Council, Sweden
Collaborator
Source ClinicalTrials.gov